BiotechTube
Home/Nyxoah/Scott Holstine
SH

Scott Holstine

Chief Commercial Officer

Nyxoah

Therapeutic Areas

Obstructive Sleep ApneaRespiratory

Nyxoah Pipeline

DrugIndicationPhase
Genio® SystemModerate to Severe Obstructive Sleep Apnea (CPAP failures)Commercial

Leadership Team at Nyxoah

OT
Olivier Taelman
Chief Executive Officer
JL
John Landry
Chief Financial Officer
BO
Bruno Onkelinx
Chief Technology Officer
MM
Maggie McGowan
Chief HR Officer
DM
Dr. Maurits S. Boon
Chief Medical Officer
RT
Robert Taub
Founder and Chairman of the Board
KR
Kevin Rakin
Independent Director
DJ
Dr. Jürgen Hambrecht
Independent Director
RJ
Rita Johnson-Mills
Independent Director
VK
Virginia Kirby
Independent Director
View full Nyxoah profile